Skip to main content

West Pharmaceutical Services Inc (WST) Stock

West Pharmaceutical Services Inc Stock Details, Movements and Public Alerts

Stock Details

West Pharmaceutical Services Inc (WST), a prominent company in the healthcare sector within the medical instruments & supplies industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $261.52. Over the past 52 weeks, it has ranged between $187.09 and $351.24. This places the current price at 74.5% of its 52-week high and 39.8% above its 52-week low. Recent trading volume was recorded at 73,497. The 14-day Relative Strength Index (RSI) stands at 53.51, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $246.17 by 6.24%. Similarly, it is above its 200-day moving average of $250.35 by 4.46%. The MACD histogram is -0.51, indicating bearish momentum (MACD Line: 3.02, Signal Line: 3.52).

Market Cap

$18.69B

52-Week High

$351.24

-25.54% from high

52-Week Low

$187.09

+39.78% from low

Avg Daily Volume

664,692

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

38.91

Above market average

Forward P/E

35.21

Earnings expected to grow

PEG Ratio

3.27

Potentially overvalued

Price to Book

6.38

EV/EBITDA

24.34

EPS (TTM)

$6.68

Price to Sales

6.31

Beta

1.05

Similar volatility to market

How is WST valued relative to its earnings and growth?
West Pharmaceutical Services Inc trades at a P/E ratio of 38.91, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 35.21 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 3.27 indicates a premium valuation even accounting for growth.
What is WST's risk profile compared to the market?
With a beta of 1.05, West Pharmaceutical Services Inc is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 6.38 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

16.50%

Operating Margin

20.90%

Return on Equity

17.70%

Return on Assets

10.50%

Revenue Growth (YoY)

9.20%

Earnings Growth (YoY)

20.50%

How profitable and efficient is WST's business model?
West Pharmaceutical Services Inc achieves a profit margin of 16.50%, meaning it retains $16.50 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 20.90% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 17.70% and ROA at 10.50%, the company generates strong returns on invested capital.
What are WST's recent growth trends?
West Pharmaceutical Services Inc's revenue grew by 9.20% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 20.50% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against MEDICAL INSTRUMENTS & SUPPLIES industry averages for proper context.

Dividend Information

Dividend Per Share

$0.83

Dividend Yield

0.33%

Ex-Dividend Date

11/12/2025

Dividend Date

11/19/2025

What dividend income can investors expect from WST?
West Pharmaceutical Services Inc offers a dividend yield of 0.33%, paying $0.83 per share annually. This modest yield below 2% suggests the company prioritizes growth investments over current income. While the dividend provides some return, investors are likely attracted more by capital appreciation potential than income generation. To receive the next dividend, shares must be purchased before the ex-dividend date of 11/12/2025.
How reliable is WST's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - West Pharmaceutical Services Inc pays $0.83 per share in dividends against earnings of $6.68 per share, resulting in a payout ratio of 12.43%. This conservative payout below 30% indicates excellent dividend safety with substantial room for future increases. The company retains most earnings for growth while still rewarding shareholders. The next dividend payment is scheduled for 11/19/2025.

Company Size & Market

Shares Outstanding

71.91M

Book Value/Share

$40.74

Asset Type

Common Stock

What is WST's market capitalization and position?
West Pharmaceutical Services Inc has a market capitalization of $18.69B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 71.91M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL INSTRUMENTS & SUPPLIES industry, it competes with other firms in this sector.
How does WST's price compare to its book value?
West Pharmaceutical Services Inc's book value per share is $40.74, while the current stock price is $261.52, resulting in a price-to-book (P/B) ratio of 6.42. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$315.92

20.80% upside potential

Analyst Recommendations

Strong Buy

2

Buy

9

Hold

2

Sell

0

Strong Sell

0

How reliable are analyst predictions for WST?
13 analysts cover WST with 85% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $315.92 implies 20.8% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on WST?
Current analyst recommendations:2 Strong Buy, 9 Buy, 2 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 26, 2025, 03:48 AM

Technical Indicators

RSI (14-day)

53.51

Neutral

50-Day Moving Average

$246.17

6.24% above MA-50

200-Day Moving Average

$250.35

4.46% above MA-200

MACD Line

3.02

MACD Signal

3.52

MACD Histogram

-0.51

Bearish

What does WST's RSI value tell investors?
The RSI (Relative Strength Index) for WST is currently 53.51, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret WST's MACD and moving average crossovers?
MACD analysis shows the MACD line at 3.02 below the signal line at 3.52, with histogram at -0.51. This bearish crossover indicates downward pressure. The 50-day MA ($246.17) is below the 200-day MA ($250.35), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Sep 26, 2025, 03:48 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for WST and get notified when the price changes.

Stay Ahead of the Market with West Pharmaceutical Services Inc Alerts

Set up price alerts for West Pharmaceutical Services Inc and get notified instantly when the price hits your target. Never miss an important price movement again.